Literature DB >> 8392318

Pathogenicity of murine cytomegalovirus for newborn mice: analysis with the attenuated mutants.

K Ibusuki1, K Kumura, Y Minamishima.   

Abstract

Mutants (ts21, rev21, and rec21w) of murine cytomegalovirus (MCMV) with reduced ability to kill newborn mice have been isolated from the Smith strain (wild type; wt). The postulated mutations for these mutants are as follows; a mutation(s) responsible for temperature sensitivity (ts); a mutation(s) responsible for attenuation (att); a mutation(s) which modifies temperature sensitivity (mts); and a mutation(s) responsible for modified growth characteristics (mgc). Genotypes of the mutants have been proposed from their phenotypes; ts21 (ts, att, mts+, mgc+); rev21 (ts, att, mts, mgc+) or (ts+, att, mts+, mgc); and rec21w (ts+, att, mts+, mgc+). Inoculation of 2.0 x 10(4) plaque forming units (PFU) of wt intraperitoneally into mice resulted in lethal infection accompanying intraperitoneal hemorrhage and pathognomonic changes in the target organs. Such changes were less in rec21w-infected mice than in wt-infected mice, and almost absent in ts21- and rev21-infected mice, on the sixth day after inoculation. The lesser damage to the organs correlated with poor growth of these viruses in the corresponding organs. On the other hand, in the case of rec21w-infected mice, virus titer in the target organs was almost equivalent to that of wt-infected mice. The growth characteristic of rec21w in the liver was also similar to that of wt. Nevertheless, damage to the organs by rec21w was less than that by wt. Comparison of the phenotypic characteristics between rec21w and wt demonstrated that att affects the ability of MCMV to induce the organ damage without affecting viral growth. Similar comparison between ts21 and rec21w revealed that ts affects the growth of MCMV in most organs.

Entities:  

Mesh:

Year:  1993        PMID: 8392318     DOI: 10.1007/bf01379085

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  24 in total

Review 1.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Independent existence of mutations responsible for temperature sensitivity and attenuation in a mutant of murine cytomegalovirus.

Authors:  K Kumura; K Ibusuki; Y Minamishima
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

3.  Virulence characteristics of murine cytomegalovirus in cell and organ cultures.

Authors:  M C Jordan; J L Takagi
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

4.  Use of temperature-sensitive mutants of mouse cytomegalovirus as vaccines.

Authors:  G R Sandford; W H Burns
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

5.  Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse.

Authors:  J E Chalmer; J S Mackenzie; N F Stanley
Journal:  J Gen Virol       Date:  1977-10       Impact factor: 3.891

6.  Virulence and attenuation of murine cytomegalovirus.

Authors:  J E Osborn; D L Walker
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

7.  Pathogenicity and immunogenicity of temperature-sensitive mutants of murine cytomegalovirus.

Authors:  Y Tonari; Y Minamishima
Journal:  J Gen Virol       Date:  1983-09       Impact factor: 3.891

8.  Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo.

Authors:  J F Bukowski; J F Warner; G Dennert; R M Welsh
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

9.  Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host.

Authors:  W Mutter; M J Reddehase; F W Busch; H J Bühring; U H Koszinowski
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen.

Authors:  A A Scalzo; N A Fitzgerald; A Simmons; A B La Vista; G R Shellam
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

View more
  1 in total

1.  Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.

Authors:  M R MacDonald; X Y Li; R M Stenberg; A E Campbell; H W Virgin
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.